| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/16/2009 | US20090099178 Indazole compounds and methods of use thereof |
| 04/16/2009 | US20090099175 Phosphodiesterase 10 inhibitors |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | US20090099143 Tetrahydro-indazole cannabinoid modulators |
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/16/2009 | CA2702132A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701932A1 Chiral cis-imidazolines |
| 04/16/2009 | CA2701880A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | CA2701568A1 Imidazole derivatives |
| 04/16/2009 | CA2700893A1 Substituted tetrazole compounds and uses thereof |
| 04/16/2009 | CA2699674A1 5-ht7 receptor antagonists |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2048141A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 04/15/2009 | EP2048137A1 Benzamide derivatives and their use as glucokinase activating agents. |
| 04/15/2009 | EP2046783A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046782A2 Imidazolylpyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046779A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 04/15/2009 | EP2046778A1 Multifunctional bioactive compounds |
| 04/15/2009 | EP2046777A2 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide |
| 04/15/2009 | EP2046774A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 04/15/2009 | EP2046762A2 Triazolyl phenyl benzenesulfonamides |
| 04/15/2009 | EP2046760A1 Macrocyclic lactams |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/15/2009 | EP1794148B1 Novel phthalazinone derivatives, as aurora-a kinase inhibitors |
| 04/15/2009 | EP1689720B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410391A 2, 3-phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410387A Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 04/15/2009 | CN101410381A Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
| 04/15/2009 | CN101410373A Bridged cyanine compounds and optical recording materials containing the same |
| 04/15/2009 | CN101407511A Crystal type glyoxaline-5-carboxyl acid derivative |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN100478341C Voriconazole derivate and preparation process thereof |
| 04/15/2009 | CN100478340C Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 04/15/2009 | CN100477995C Fortifier |
| 04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517903 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity |
| 04/14/2009 | US7517902 1-[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl-phenyl)urea; protein kinases (Vascular Endothelial Growth Factor Receptor 2 and Tie-2), inhibitor; anticarcinogenic, antiinflammatory agent; neovascularization, lung and breast cancer, rheumatoid arthritis |
| 04/14/2009 | US7517900 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/14/2009 | US7517881 Triazine derivatives, their preparation and therapeutic application thereof |
| 04/14/2009 | US7517878 For example, 2-([3-tert-butyl-1-(2-methylphenyl)-1H-pyrazol-5-yl]amino)-6-methylnicotinic acid; compounds stimulate insulin secretion in the presence of glucose |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517871 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors |
| 04/09/2009 | WO2009045314A1 Gamma secretase modulators |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044211A1 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 04/09/2009 | WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 04/09/2009 | WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2009043883A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2009043780A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | WO2009043747A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 04/09/2009 | WO2009021868A3 Novel piperazine amide derivatives |
| 04/09/2009 | WO2009019472A4 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 04/09/2009 | WO2008155670A3 Arylamide pyrimidone compounds |
| 04/09/2009 | WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 04/09/2009 | WO2008152093A3 Diaminopyrimidines as modulators of the ep2 receptor |
| 04/09/2009 | WO2008151927A3 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 04/09/2009 | WO2008148867A3 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | US20090093628 Process for Production of Amides or Lactams |
| 04/09/2009 | US20090093498 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
| 04/09/2009 | US20090093494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents |
| 04/09/2009 | US20090093481 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093472 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 04/09/2009 | US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/09/2009 | US20090093464 Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/09/2009 | US20090093417 angiotensin II type 1 (AT1) receptor antagonist activity and neprilysin inhibition activity; aryl compounds with both tert-amide and another tert or sec-amide group |
| 04/09/2009 | CA2738980A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 04/09/2009 | CA2701414A1 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701214A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | CA2701203A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 04/09/2009 | CA2700964A1 Gamma secretase modulators |
| 04/09/2009 | CA2700691A1 New biaryl derivatives |
| 04/08/2009 | EP2045250A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same |
| 04/08/2009 | EP2044938A2 Radioprotectors |
| 04/08/2009 | EP2044058A1 Chemical compounds |
| 04/08/2009 | EP2044051A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 04/08/2009 | EP2044032A2 Novel inhibitors of hepatitis c virus replication |
| 04/08/2009 | EP2044031A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/08/2009 | EP2044027A2 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/08/2009 | EP2044019A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 04/08/2009 | EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 04/08/2009 | EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system |